Glide(US) | $15,000,000 | (May 9, 2025)
Kouper | $10,000,000 | (May 9, 2025)
Doubleword (prev. TitanML) | $12,000,000 | (May 9, 2025)
Certified by Founder
Lodge
Latigo Biotherapeutics, Inc.
start up
United States
- Thousand Oaks, CA
- 15/02/2024
- Series A
- $135,000,000
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
- Industry Biotechnology Research
- Website https://latigobio.com/
- LinkedIn https://www.linkedin.com/company/latigobio/
VESTIGAS | $9,003,240 | (May 9, 2025)
HAYA Therapeutics | $65,000,000 | (May 9, 2025)
Una Software | $4,400,000 | (May 9, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)
Jozu | $4,000,000 | (May 9, 2025)
PATH EX, Inc. | $5,000,000 | (May 9, 2025)
Blank Beauty | Undisclosed Amount | (May 9, 2025)
Pulse Charter Connect | $2,000,000 | (May 9, 2025)
CodeAnt AI (YC W24) | $2,000,000 | (May 8, 2025)